Assertio Therapeutics
ASRTAssertio Therapeutics, Inc. (formally Depomed, Inc.) is an American specialty pharmaceutical company. It mainly markets products for treatment in neurology, pain and diseases of the central nervous system. Depomed was founded in 1995 and is headquartered in Newark, California. It is a publicly trade …
© Wikipedia /
Creative Commons CC-BY-SA 3.0 more at Wikipedia
Insider trades and stock quote 2023-2025
All insider trades at Assertio Therapeutics
Subscribe RSS| Date | Type | Insider | Position | Ø-Price | Volume |
|---|---|---|---|---|---|
| 11/18/2024 | Buy | Mason, Heather L. | Director | $0.8 | $60,000 |
| 11/14/2024 | Buy | O'grady, Brendan P. | CEO | $0.9 | $9,950 |
| 6/11/2024 | Buy | Vacirca, Jeff L. | Director | $1.1 | $11,100 |
| 6/5/2024 | Buy | Mason, Heather L. | Interim Executive Officer | $1.0 | $24,250 |
| 3/14/2024 | Sell | Tyree, James L. | Director | $1.1 | $11,463 |
All information without guarantee! No recommendation/consultation!
© U.S. Securities and Exchange Commission (SEC)